发明名称 |
TARGETED TREATMENT OF LEIOMYOSARCOMA |
摘要 |
A method and medicament comprising 4,4,4-trifluoro-N-[(1S)-2-[[(7S)-5-(2- hydroxyethyl)-6-oxo-7H-pyrido[2,3-d][3]benzazepin-7-yl]amino]-1-methyl-2-oxo- ethyl]butanamide or a pharmaceutically acceptable salt or hydrate thereof for treating leiomyosarcoma is provided. |
申请公布号 |
WO2016168014(A1) |
申请公布日期 |
2016.10.20 |
申请号 |
WO2016US26119 |
申请日期 |
2016.04.06 |
申请人 |
ELI LILLY AND COMPANY |
发明人 |
BENHADJI, Karim A.;MASSARD, Christophe;SORIA, Jean-Charles |
分类号 |
A61K31/55;A61P35/00 |
主分类号 |
A61K31/55 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|